Wealth Enhancement Advisory Services
VNDA icon

Wealth Enhancement Advisory Services’s Vanda Pharmaceuticals VNDA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Buy
97,400
+49,077
+102% +$321K ﹤0.01% 2639
2026
Q1 		$338K Buy
48,323
+24,910
+106% +$192K ﹤0.01% 2659
2025
Q4 		$190K Buy
23,413
+5,913
+34% +$32.5K ﹤0.01% 3289
2025
Q3 		$93K Buy
+17,500
New +$81K ﹤0.01% 3348

Other funds holding VNDA

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Wealth Enhancement Advisory Services's VNDA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Vanda Pharmaceuticals (VNDA) stake by 102% in Q2 2026, buying an estimated $321K and bringing the position to 97,400 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #2639.

Wealth Enhancement Advisory Services first reported a position in VNDA in Q3 2025 and has held it in 4 quarters since. 15 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Wealth Enhancement Advisory Services held 97,400 shares of Vanda Pharmaceuticals worth $525K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 49,077 Vanda Pharmaceuticals shares in Q2 2026, an estimated $321K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2639 holding.
  • Wealth Enhancement Advisory Services first reported a position in Vanda Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 15 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.